PMV Pharmaceuticals Inc【PMVP】株式ニュース

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

Form 4 - Statement of changes in beneficial ownership of securities

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form 8-K - Current report

PMV Pharmaceuticals Reports Full Year 2024 Financial Results and Corporate Highlights

Enrollment on track in Phase 2 pivotal portion of PYNNACLE clinical trial evaluating rezatapopt as monotherapy...

PMV Pharmaceuticals to Participate at Upcoming Investor Conferences

PRINCETON, N.J., Feb. 11, 2025 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision...

Form S-8 - Securities to be offered to employees in employee benefit plans

Form EFFECT - Notice of Effectiveness

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form S-3 - Registration statement under Securities Act of 1933

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

PMV Pharmaceuticals Reports Third Quarter 2024 Financial Results

Enrollment on track in Phase 2 portion of PYNNACLE clinical trial evaluating rezatapopt as monotherapy in...

PMV Pharmaceuticals Provides a Progress Update on PYNNACLE Clinical Trial

Enrollment on track in registrational Phase 2 portion of PYNNACLE clinical trial evaluating rezatapopt as...

Form 4 - Statement of changes in beneficial ownership of securities

PMVP had a great move over $3 but then lost control of the jet and sank quickly.

👍️0

Mt. Blanc 1年前

PMVP into the cup and handle chart setup. On radar to begin climbing the great wall of worry.

mb

👍️0

Mt. Blanc 1年前

$PMVP trading in the low $2's for now but at some point, this starts to firm up well into 2024+.

mb

👍️0

Mt. Blanc 1年前

PMVP will be under radar for a while until it catches fire and then will be seen.

mb

👍️0

crudeoil24 3年前

2022 American Society of Clinical Oncology (ASCO) Annual Meeting

👍️0

crudeoil24 3年前

JUNE 7 > Updated data from ongoing Phase 1/2 PYNNACLE trial to be presented .

👍️0

crudeoil24 3年前

PMV Pharma Shares Rise 17%; Company to Present Data on PYNNACLE Phase 1 Trial
6:46 pm ET May 26, 2022 (Dow Jones) Print

By Stephen Nakrosis

Shares of PMV Pharmaceuticals Inc. were trading higher in Thursday's after-hours market, following the company's announcement that it would be presenting data from its lead program, PC14586, at the 2022 American Society of Clinical Oncology meeting next month.

PMV said its abstract describes "preliminary outcomes from 29 patients, including 21 efficacy evaluable, from the ongoing Phase 1/2 PYNNACLE trial of PC14586 in patients with advanced solid tumors that have a p53 Y220C mutation." PMV said the preliminary results "represent the first clinical evidence of targeting a p53 Y220C mutation."

At 6:37 p.m. ET, PMV's shares were trading 17.79% higher at $15.56 a share. Volume at the time topped 2.1 million shares. The company's stock finished the day with a 0.92% gain, closing at $13.21 a share.

Write to Stephen Nakrosis at stephen.nakrosis@wsj.com

(END) Dow Jones Newswires

PMVP

👍️0

crudeoil24 3年前

PMV Pharmaceuticals, Inc. is a precision oncology company, which is engaged in the discovery and development of small molecule, tumor-agnostic therapies targeting p53. The Company’s lead product candidate, PC14586, is an orally available small molecule designed to potently and selectively correct p53 misfolding caused by a specific p53 mutation, Y220C, while sparing wild type p53. PC14586 is designed to restore the wild-type conformation by occupying the crevice created by the tyrosine to cysteine mutation in amino acid position 220. The Company is also using its precision oncology platform to develop a pipeline of oral small molecule product candidates, which structurally correct other p53 hotspot mutations to restore their wild-type function and product candidates that target certain cancers where wild-type p53 function is silenced.

PMVP

👍️0

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

PMV Pharmaceuticals Inc (PMVP)

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

PMVP ニュース

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form 8-K - Current report

PMV Pharmaceuticals Reports Full Year 2024 Financial Results and Corporate Highlights

PMV Pharmaceuticals to Participate at Upcoming Investor Conferences

Form S-8 - Securities to be offered to employees in employee benefit plans

Form EFFECT - Notice of Effectiveness

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form S-3 - Registration statement under Securities Act of 1933

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

PMV Pharmaceuticals Reports Third Quarter 2024 Financial Results

PMV Pharmaceuticals Provides a Progress Update on PYNNACLE Clinical Trial

Form 4 - Statement of changes in beneficial ownership of securities

PMVP Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

PMV Pharmaceuticals Inc (PMVP) ニュース

PMV Pharmaceuticals Inc (PMVP)

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

PMVP ニュース

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form 8-K - Current report

PMV Pharmaceuticals Reports Full Year 2024 Financial Results and Corporate Highlights

PMV Pharmaceuticals to Participate at Upcoming Investor Conferences

Form S-8 - Securities to be offered to employees in employee benefit plans

Form EFFECT - Notice of Effectiveness

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form S-3 - Registration statement under Securities Act of 1933

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

PMV Pharmaceuticals Reports Third Quarter 2024 Financial Results

PMV Pharmaceuticals Provides a Progress Update on PYNNACLE Clinical Trial

Form 4 - Statement of changes in beneficial ownership of securities

PMVP Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

広告を削除する